Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Depression and Anxiety|April 1, 2015
Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment responseDean T Acheson, David Feifel, Mary Kamenski, et al.
Hormones and Behavior|September 2, 2023
Four-week intranasal oxytocin administration reduces attachment avoidance in older womenKylie A Wright, Rebecca Polk, Tian Lin, et al.
The Western Journal of Emergency Medicine|March 31, 2012
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroupMichael P Wilson, David Pepper, Glenn W Currier, et al.
Biological Psychiatry|September 1, 2004
Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorderDavid Feifel, Robert H Farber, Brett A Clementz, et al.
General Hospital Psychiatry|May 11, 2005
Rapid oral loading of extended release divalproex in patients with acute maniaBrian P Miller, William Perry, Christine Y Moutier, et al.
Psychopharmacology|May 7, 2013
The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sampleDean Acheson, David Feifel, Sofieke de Wilde, et al.
Brain Research|September 24, 2013
Assessment of attention in male and female Brattleboro rats using a self-paced five-choice serial reaction time taskMichael D Berquist Ii, Sean M Mooney-Leber, David Feifel, et al.
Psychoneuroendocrinology|March 10, 2024
Effects of chronic intranasal oxytocin on visual attention to faces vs. natural scenes in older adultsAlayna Shoenfelt, Didem Pehlivanoglu, Tian Lin, et al.
Pageof 11